PEARKO Therapeutics Inc.
$295,500.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
FY 2021-2022
Canada
PEARKO Therapeutics has been developing ApelinPlus (apelin analog) which can be a treatment for cardiovascular diseases. Currently, we are conducting preclinical testing of ApelinPlus, establishing re...